Cowealth Medical Holding Co., Ltd. (TPEX:4745)
9.60
-0.38 (-3.81%)
Nov 20, 2026, 1:30 PM CST
Cowealth Medical Holding Revenue
Cowealth Medical Holding had revenue of 817.61M TWD in the quarter ending September 30, 2026, with 5.97% growth. This brings the company's total for the last twelve months to 2.95B, down -13.59% year-over-year. In the year 2025, Cowealth Medical Holding had annual revenue of 2.96B, down -29.49%. That makes Cowealth Medical Holding the 23,587th largest company in the world by revenue and 1,007th in Taiwan.
Revenue (ttm)
2.95B
Revenue Growth
-13.59%
P/S Ratio
0.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
635.72M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Cowealth Medical Holding breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.96B | -1.24B | -29.49% |
| Dec 31, 2024 | 4.19B | -619.85M | -12.88% |
| Dec 31, 2023 | 4.81B | -813.80M | -14.46% |
| Dec 31, 2022 | 5.63B | 486.62M | 9.47% |
| Dec 31, 2021 | 5.14B | 417.81M | 8.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| Bioptik Technology Incorporation | 891.73M |
| Diamond Biotechnology | 464.63M |
| Radiant Innovation | 417.97M |
| Wiltrom | 314.12M |
| S&S Healthcare Holding | 185.52M |
| PlexBio | 137.57M |
| AmCad BioMed | 26.16M |